Bayesian models to estimate causal effects of biological
treatments on time-to-event endpoints in clinical trials with principal
strata defined by the occurrence of antidrug antibodies.
The methodology is based on Frangakis and Rubin (2002)
<doi:10.1111/j.0006-341x.2002.00021.x> and Imbens and Rubin (1997)
<doi:10.1214/aos/1034276631>, and here adapted to a specific
time-to-event setting.
Version: |
0.0.7 |
Depends: |
R (≥ 3.4.0) |
Imports: |
dplyr, furrr, magrittr, methods, purrr, Rcpp (≥ 0.12.0), RcppParallel (≥ 5.0.1), rstan (≥ 2.18.1), rstantools (≥
2.4.0), stats, stringr, tibble |
LinkingTo: |
BH (≥ 1.66.0), Rcpp (≥ 0.12.0), RcppEigen (≥ 0.3.3.3.0), RcppParallel (≥ 5.0.1), rstan (≥ 2.18.1), StanHeaders (≥
2.18.0) |
Suggests: |
spelling |
Published: |
2024-04-13 |
DOI: |
10.32614/CRAN.package.BPrinStratTTE |
Author: |
Christian Stock
[aut, cre],
Emma Torrini [aut],
Boehringer Ingelheim Pharma GmbH & Co. KG [cph, fnd] |
Maintainer: |
Christian Stock <christian.stock at boehringer-ingelheim.com> |
BugReports: |
https://github.com/Boehringer-Ingelheim/BPrinStratTTE/issues |
License: |
GPL (≥ 3) |
URL: |
https://github.com/Boehringer-Ingelheim/BPrinStratTTE,
https://boehringer-ingelheim.github.io/BPrinStratTTE/ |
NeedsCompilation: |
yes |
SystemRequirements: |
GNU make |
Language: |
en-US |
Materials: |
README NEWS |
CRAN checks: |
BPrinStratTTE results |